Neuropace Inc — Quarterly Financial Data (NASDAQ:NPCE) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Dividends per share —0000 0 Dividend yield % —0——0 — Payout ratio % —0000 0

新闻

LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates

Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates

Leerink Partners将NeuroPace股票目标价从19美元上调至20美元

NeuroPace stock price target raised to $20 from $19 at Leerink Partners

NeuroPace stock price target raised to $19 from $18 at H.C. Wainwright

NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

NeuroPace股价上涨，UBS在强劲第四季度收入后重申买入评级

NeuroPace stock rises as UBS reiterates Buy rating after strong Q4 revenue

NeuroPace公司2025年收入增长25%，预计稳定增长

NeuroPace reports 25% revenue growth for 2025, projects steady growth